Demetrix Inc CEO on Potential of Cannabinoid Biosynthesis and Series A Financing

Share on facebook
Share on twitter
Share on linkedin
Share on email

Demetrix Inc is a biosynthesis company producing rare, natural ingredients via fermentation. CEO Jeff Ubersax states that the company’s goal is to produce rare ingredients at a higher purity and consistency than traditional sources for use in consumer packaged goods in the pharmaceutical, health supplements, and cosmetics spaces. Ubersax reveals that the first ingredients Demetrix is planning to bring to market are cannabinoid-based. He credits the company’s seed financing round, in which Demetrix raised approximately $11 million, with allowing the company to put together an experienced team. He suggests that new technology, both on the plant side as well as the microbe side, will bring the cost of goods down; however, he believes that fermentation-derived products will be the most cost effective way to produce the rarest cannabinoids. Demetrix is in the midst of Series A financing and hopes to close this capital raise within the next couple of months.


Check out our website:



SUBSCRIBE to our YouTube:

SUBSCRIBE to our 2nd YouTube Channel – Midas Letter Clips:

SUBSCRIBE to our Newsletter:

Download Our Podcast on iTunes:


Follow Us on Twitter:

Like Us on Instagram:

Like Us on Facebook:



View original source video by clicking here

On Key

Related Posts


Join me in this 5 min APARTMENT FRIENDLY (no jumping) warm up routine for at home workouts! Warming up is so important and you should be warming up before EVERY single workout! DOWNLOAD YOUR MADFIT APP FREE TRIAL HERE: #WithMe #WarmUp #HomeWorkout THE MAT I USE (Exercise 6X4): (MADFIT10 for 10% off) SUBSCRIBE…